Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8715217 | Journal of the American Academy of Dermatology | 2018 | 19 Pages |
Abstract
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. Topics addressed include biopsy techniques and histopathologic assessment, tumor staging, surgical and nonsurgical management, follow-up and prevention of recurrence, and management of advanced disease. The primary focus of these recommendations is on evaluation and management of primary cSCC and localized disease, but where relevant, applicability to recurrent cSCC is noted, as is general information on the management of patients with metastatic disease.
Keywords
SOTR5-FUBWHAADBCCSLNBCSCCMMSNCCNAJCCRCTRandomized controlled trialAmerican Academy of DermatologyBiopsyBrigham and Women's Hospitalcomputed tomographyMohs micrographic surgerytopical therapyRadiotherapyNational Comprehensive Cancer NetworkSurgeryPhototherapy5-fluorouracilMetastasisPrincipal investigatorStagingmalignant melanomaSurveillanceSentinel lymph node biopsyBasal cell carcinomaSquamous cell carcinomacutaneous squamous cell carcinomaAmerican Joint Committee on CancerCurettageSolid organ transplant recipient
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology